News | January 21, 2015

Avera Health Partners with Elekta to Deliver Advanced Cancer Care

Elekta’s Mosaiq OIS, other systems will be deployed across six regional locations and 40 outreach sites

Elekta, Avera Health Partners, agreement, Mosaiq, radiation therapy, oncology

Leksell Gamma Knife Perfexion. Image courtesy of Elekta.

January 21, 2015 — To provide high-quality, evidence-based cancer care throughout South Dakota, Minnesota and other surrounding states, Avera Health and Elekta announced a partnership to deploy Mosaiq oncology information system across the Avera Cancer Institute.

This partnership will enable Avera to implement an integrated oncology health system that spans the full cancer care continuum, from prevention and screening through to palliation and recovery.

The agreement includes Elekta linear accelerators (Versa HD, Elekta Infinity), Leksell Gamma Knife Perfexion and brachytherapy solutions, Monaco treatment planning and Metriq cancer registry software. All of the software will be deployed through a cloud-based solution.

"By choosing Elekta as our partner, we will be able to give our patients access to the world's most advanced technology for treating cancer," says Michael Peterson, M.D., radiation oncologist with Avera Health. "Having both Versa HD and Perfexion provides superior capabilities for stereotactic treatment delivery, enabling us to perform treatments faster, with even greater precision."

Cancer is the second leading cause of death in the United States and South Dakota,* which has a population of about 850,000. The agreement will benefit Avera's six regional locations and 40 outreach sites by driving further improvements in quality patient care.

For more information: www.elekta.com

Related Content

World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...
News | Proton Therapy | June 16, 2020
June 17, 2020 — RaySearch Laboratories AB launched the latest release of its widely adopted treatment planning system
Vacancy rates for radiation therapists rose substantially since 2018, according to a survey performed this year by the American Society of Radiologic Technologists. Researchers noted, however, the survey data was collected before the COVID-19 pandemic began affecting the surveyed clinical settings.

Getty Images

News | Radiation Therapy | June 05, 2020
June 5, 2020 — Vacancy rates for radiation therapists rose substantially since 2018, according to a survey performed
MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

 

News | Radiation Therapy | June 01, 2020
June 1, 2020 — RefleXion Medical, a therape